141 related articles for article (PubMed ID: 12602490)
1. Physicochemical properties of amphotericin B liposomes prepared by reverse-phase evaporation method.
Rojanapanthu P; Sarisuta N; Chaturon K; Kraisintu K
Drug Dev Ind Pharm; 2003 Jan; 29(1):31-7. PubMed ID: 12602490
[TBL] [Abstract][Full Text] [Related]
2. Characterization of amphotericin B liposome formulations.
Manosroi A; Kongkaneramit L; Manosroi J
Drug Dev Ind Pharm; 2004 May; 30(5):535-43. PubMed ID: 15244089
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of size-based distribution of drug and excipient in amphotericin B liposomal formulation.
Van Haute D; Jiang W; Mudalige T
Int J Pharm; 2019 Oct; 569():118603. PubMed ID: 31401296
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Binding of Antifungal Antibiotic Amphotericin B to Lipid Membranes: An Insight from Combined Single-Membrane Imaging, Microspectroscopy, and Molecular Dynamics.
Grela E; Wieczór M; Luchowski R; Zielinska J; Barzycka A; Grudzinski W; Nowak K; Tarkowski P; Czub J; Gruszecki WI
Mol Pharm; 2018 Sep; 15(9):4202-4213. PubMed ID: 30081640
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
Changsan N; Chan HK; Separovic F; Srichana T
J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
[TBL] [Abstract][Full Text] [Related]
6. Phase behaviour of amphotericin B multilamellar vesicles.
Hamilton KS; Barber KR; Davis JH; Neil K; Grant CW
Biochim Biophys Acta; 1991 Feb; 1062(2):220-6. PubMed ID: 1848451
[TBL] [Abstract][Full Text] [Related]
7. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
8. Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes.
Szoka F; Olson F; Heath T; Vail W; Mayhew E; Papahadjopoulos D
Biochim Biophys Acta; 1980 Oct; 601(3):559-71. PubMed ID: 6251878
[TBL] [Abstract][Full Text] [Related]
9. Ligand directed macrophage targeting of amphotericin B loaded liposomes.
Vyas SP; Katare YK; Mishra V; Sihorkar V
Int J Pharm; 2000 Dec; 210(1-2):1-14. PubMed ID: 11163983
[TBL] [Abstract][Full Text] [Related]
10. Effect of different preparation methods on physicochemical properties of salidroside liposomes.
Fan M; Xu S; Xia S; Zhang X
J Agric Food Chem; 2007 Apr; 55(8):3089-95. PubMed ID: 17373810
[TBL] [Abstract][Full Text] [Related]
11. Physical biochemistry of a liposomal amphotericin B mixture used for patient treatment.
Grant CW; Hamilton KS; Hamilton KD; Barber KR
Biochim Biophys Acta; 1989 Aug; 984(1):11-20. PubMed ID: 2548619
[TBL] [Abstract][Full Text] [Related]
12. Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products.
Liu Y; Mei Z; Mei L; Tang J; Yuan W; Srinivasan S; Ackermann R; Schwendeman AS
Eur J Pharm Biopharm; 2020 Dec; 157():241-249. PubMed ID: 32980448
[TBL] [Abstract][Full Text] [Related]
13. Preparation by spray drying of amphotericin B-phospholipid composite particles and their anticellular activity.
Kim JC; Kim JD
Drug Deliv; 2001; 8(3):143-7. PubMed ID: 11570594
[TBL] [Abstract][Full Text] [Related]
14. Multilayered vesicles prepared by reverse-phase evaporation: liposome structure and optimum solute entrapment.
Pidgeon C; McNeely S; Schmidt T; Johnson JE
Biochemistry; 1987 Jan; 26(1):17-29. PubMed ID: 3828297
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical and immunological properties of albumin-associated dialkyl-ether phosphatidylcholine liposomes.
Shek PN; Yung BY; Stanacev NZ
Biochim Biophys Acta; 1986 Feb; 855(1):33-40. PubMed ID: 3942744
[TBL] [Abstract][Full Text] [Related]
16. Study of amphotericin B magnetic liposomes for brain targeting.
Zhao M; Hu J; Zhang L; Zhang L; Sun Y; Ma N; Chen X; Gao Z
Int J Pharm; 2014 Nov; 475(1-2):9-16. PubMed ID: 25151436
[TBL] [Abstract][Full Text] [Related]
17. Preclinical & pharmaceutical testing of liposomal amphotericin B.
Gokhale PC; Kotwani RN; Dange SY; Kshirsagar NA; Pandya SK
Indian J Med Res; 1993 Apr; 98():75-8. PubMed ID: 8344735
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory activity of liposomes of
Plangsombat N; Rungsardthong K; Kongkaneramit L; Waranuch N; Sarisuta N
Exp Ther Med; 2016 Oct; 12(4):2790-2796. PubMed ID: 27698785
[No Abstract] [Full Text] [Related]
19. Hemolytic and antifungal activity of liposome-entrapped amphotericin B prepared by the precipitation method.
Kim JC; Lee EO; Kim JY; Bae SK; Choi TB; Kim JD
Pharm Dev Technol; 1997 Aug; 2(3):275-84. PubMed ID: 9552455
[TBL] [Abstract][Full Text] [Related]
20. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
